|
VK-2809
|
DB15137 |
[VK-2809 is under investigation in clinical trial NCT02927184 (Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease).] |
|
Rebaudioside A
|
DB15136 |
[Rebaudioside A is under investigation in clinical trial NCT03510624 (Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus).] |
|
Interferon alfa-2c
|
DB15131 |
[Interferon alfa-2c is under investigation in clinical trial NCT00485563 (A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma).] |
|
Dexpramipexole
|
DB15130 |
[Dexpramipexole is under investigation in clinical trial NCT01511029 (Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)).] |
|
Tepotinib
|
DB15133 |
[Tepotinib is under investigation in clinical trial NCT03531762 (Effect of a Proton Pump Inhibitor on the Pharmacokinetics (PK) of Tepotinib).] |
|
AZD-8165
|
DB15132 |
[AZD-8165 is under investigation in clinical trial NCT01150812 (Oral AZD8165 After Single Oral Ascending Doses in Healthy Male Subjects).] |
|
CRA_8696
|
DB03159 |
|
|
(6r,7r)-3-[(Acetyloxy)Methyl]-7-{[(6s)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Octane-2-Carboxylate
|
DB04488 |
|
|
N,O-Didansyl-L-Tyrosine
|
DB03157 |
|
|
D-Myo-Inositol-1,4-Bisphosphate
|
DB03158 |
|
|
Guanidinoethylmercaptosuccinic acid
|
DB04489 |
|
|
(2s)-2,8-Diaminooctanoic Acid
|
DB04486 |
|
|
2'-fluoro-2'-deoxyuridine 3'-monophosphate
|
DB03155 |
|
|
beta-D-glucuronic acid
|
DB03156 |
|
|
N-Methylleucine
|
DB04487 |
|
|
4-Methylpiperazin-1-Yl Carbonyl Group
|
DB04451 |
|
|
Para-Toluene Sulfonate
|
DB03120 |
|
|
(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid
|
DB03121 |
|
|
Aminoquinuride
|
DB04452 |
|
|
Heptyl 1-Thiohexopyranoside
|
DB04450 |
|
